Return On Equity	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021
Y / Y Equity Change	-	-	-	89.62 %	63.02 %
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

OTLK all Ratios >> Back to OTLK Management Effectiveness >> See Quarterly OTLK Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Sep 30 2025) ROE improved to 193.94 % compare to previous year, due to net income growth.

Financial Statements
Outlook Therapeutics Inc 's Equity	$ -32 Millions	Annual OTLK's Balance sheet
Outlook Therapeutics Inc 's Annual Income	$ -62 Millions	Annual OTLK's Income Statement
Where are OTLK's Income coming from?		Visit OTLK's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.